The University of Southampton
University of Southampton Institutional Repository

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
The association of genetic lesions detected by fluorescence in situ hybridization (FISH) with survival was analyzed in 1069 patients with newly presenting myeloma treated in the Medical Research Council Myeloma IX trial, with the aim of identifying patients associated with the worst prognosis. A comprehensive FISH panel was performed, and the lesions associated with short progression-free survival and overall survival (OS) in multivariate analysis were +1q21, del(17p13) and an adverse immunoglobulin heavy chain gene (IGH) translocation group incorporating t(4;14), t(14;16) and t(14;20). These lesions frequently co-segregated, and there was an association between the accumulation of these adverse FISH lesions and a progressive impairment of survival. This observation was used to define a series of risk groups based on number of adverse lesions. Taking this approach, we defined a favorable risk group by the absence of adverse genetic lesions, an intermediate group with one adverse lesion and a high-risk group defined by the co-segregation of >1 adverse lesion. This genetic grouping was independent of the International Staging System (ISS) and so was integrated with the ISS to identify an ultra-high-risk group defined by ISS II or III and >1 adverse lesion. This group constituted 13.8% of patients and was associated with a median OS of 19.4 months.
0887-6924
349-355
Boyd, K.D.
d381c720-52cd-4667-ba00-1f9fc41d474b
Ross, F.M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Chiecchio, L.
48f9d8f0-c80c-4486-af21-2cd4a27810bc
Dagrada, G.P.
5af7a8c6-2db5-4d7c-8936-e21ada0bfc28
Konn, Z.J.
525b4648-7c88-488a-aefa-0018ac485eb4
Tapper, W.J.
9d5ddc92-a8dd-4c78-ac67-c5867b62724c
Walker, B.A.
d808cee3-7459-4d1a-af1a-be12674488a8
Wardell, C.P.
4b4e2405-c2cc-48d8-ba35-5089891fa8ea
Gregory, W.M.
cea7c53e-3baa-43af-89f2-94d783c3596f
Szubert, A.J.
cd05f3b2-afea-488e-96bc-91a7fb5d5121
Bell, S.E.
b0d7fa96-d143-4bb3-8536-174496c46083
Child, J.A.
3f0bf8be-5747-4d64-9ff1-dda4d252f410
Jackson, G.H.
2c9befc0-cbef-4b4c-81d8-a04766e23270
Davies, F.E.
3db5c54e-9852-4caf-91d9-8b339f68a632
Morgan, G.J.
7e5206cc-8a58-410c-9ea5-9022b1532ace
Boyd, K.D.
d381c720-52cd-4667-ba00-1f9fc41d474b
Ross, F.M.
ec0958f8-b992-4e4a-b7e3-c474600390ba
Chiecchio, L.
48f9d8f0-c80c-4486-af21-2cd4a27810bc
Dagrada, G.P.
5af7a8c6-2db5-4d7c-8936-e21ada0bfc28
Konn, Z.J.
525b4648-7c88-488a-aefa-0018ac485eb4
Tapper, W.J.
9d5ddc92-a8dd-4c78-ac67-c5867b62724c
Walker, B.A.
d808cee3-7459-4d1a-af1a-be12674488a8
Wardell, C.P.
4b4e2405-c2cc-48d8-ba35-5089891fa8ea
Gregory, W.M.
cea7c53e-3baa-43af-89f2-94d783c3596f
Szubert, A.J.
cd05f3b2-afea-488e-96bc-91a7fb5d5121
Bell, S.E.
b0d7fa96-d143-4bb3-8536-174496c46083
Child, J.A.
3f0bf8be-5747-4d64-9ff1-dda4d252f410
Jackson, G.H.
2c9befc0-cbef-4b4c-81d8-a04766e23270
Davies, F.E.
3db5c54e-9852-4caf-91d9-8b339f68a632
Morgan, G.J.
7e5206cc-8a58-410c-9ea5-9022b1532ace

Boyd, K.D., Ross, F.M., Chiecchio, L., Dagrada, G.P., Konn, Z.J., Tapper, W.J., Walker, B.A., Wardell, C.P., Gregory, W.M., Szubert, A.J., Bell, S.E., Child, J.A., Jackson, G.H., Davies, F.E. and Morgan, G.J. (2012) A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial. Leukemia, 26 (2), 349-355. (doi:10.1038/leu.2011.204). (PMID:21836613)

Record type: Article

Abstract

The association of genetic lesions detected by fluorescence in situ hybridization (FISH) with survival was analyzed in 1069 patients with newly presenting myeloma treated in the Medical Research Council Myeloma IX trial, with the aim of identifying patients associated with the worst prognosis. A comprehensive FISH panel was performed, and the lesions associated with short progression-free survival and overall survival (OS) in multivariate analysis were +1q21, del(17p13) and an adverse immunoglobulin heavy chain gene (IGH) translocation group incorporating t(4;14), t(14;16) and t(14;20). These lesions frequently co-segregated, and there was an association between the accumulation of these adverse FISH lesions and a progressive impairment of survival. This observation was used to define a series of risk groups based on number of adverse lesions. Taking this approach, we defined a favorable risk group by the absence of adverse genetic lesions, an intermediate group with one adverse lesion and a high-risk group defined by the co-segregation of >1 adverse lesion. This genetic grouping was independent of the International Staging System (ISS) and so was integrated with the ISS to identify an ultra-high-risk group defined by ISS II or III and >1 adverse lesion. This group constituted 13.8% of patients and was associated with a median OS of 19.4 months.

This record has no associated files available for download.

More information

Published date: February 2012
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 337683
URI: http://eprints.soton.ac.uk/id/eprint/337683
ISSN: 0887-6924
PURE UUID: c76909e8-3007-4a6a-ad94-0fa1344e20fb
ORCID for W.J. Tapper: ORCID iD orcid.org/0000-0002-5896-1889

Catalogue record

Date deposited: 02 May 2012 11:27
Last modified: 15 Mar 2024 03:02

Export record

Altmetrics

Contributors

Author: K.D. Boyd
Author: F.M. Ross
Author: L. Chiecchio
Author: G.P. Dagrada
Author: Z.J. Konn
Author: W.J. Tapper ORCID iD
Author: B.A. Walker
Author: C.P. Wardell
Author: W.M. Gregory
Author: A.J. Szubert
Author: S.E. Bell
Author: J.A. Child
Author: G.H. Jackson
Author: F.E. Davies
Author: G.J. Morgan

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×